Cheng-Jun Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cheng-Jun Zhou has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Ting-Guo Zhang
Department of Pathology, Qilu Hospital, Shandong University
3 shared publicationsBin Liu
Department of Digestive Disease, The Second Hospital, Shandong University, Jinan, Shandong 250033, People's Republic of China
2 shared publicationsJian-Qiang Guo
2 shared publicationsJiaqi Chen
Department of Pathology, Beijing Chaoyang Hospital of Capital Medical University, Beijing, China
2 shared publications- Qing-Hui Zhang
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA
2 shared publications Shan-Zhen Sun
2 shared publications
Latest Publications
- Open Access
- 4 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Clinicopathological features and mucin expression of early papillary gastric adenocarcinoma
Early papillary gastric adenocarcinoma (EPGA), a well-differentiated gastric adenocarcinoma, is characterized by higher malignancy and worse prognosis compared to other differentiated gastric adenocarcinomas. Therefore, there is a critical need to elucidate its clinicopathological features and mucin expression for accurate diagnosis. The data of 116 cases of EPGA and 116 cases of early well-moderately differentiated tubular gastric adenocarcinoma (ETGA) diagnosed via pathological examination following radical gastrectomy from January 2016 to December 2023 at the Second Hospital of Shandong University were collected. Multivariable logistic regression was used to conduct a comparative analysis of the two groups of variables. The features of histological grading and immunophenotype, particularly mucin expression, were specifically analyzed. The receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic efficacy of potential biomarkers in distinguishing EPGA from ETGA. The features of histological grading and MUC5AC expression in EPGA were specifically analyzed. Additionally, the risk factors of LVI in early gastric cancer (EGC) were assessed. EPGA exhibited significantly larger size (P < 0.001), higher frequencies of elevated appearance (P = 0.001), ulcer formation (P = 0.010) and lymphovascular invasion (LVI, P = 0.050) compared to ETGA. The expression of mismatch repair-deficient (P = 0.005) and MUC5AC (P < 0.001) were significantly elevated in EPGA compared to ETGA. Compared to ETGA, high-grade EPGA exhibited a greater incidence of ulcer formation (P < 0.001), submucosal invasion (P = 0.007), LVI (P = 0.010) and microsatellite instability-high (MSI-H, P < 0.001), whereas low-grade EPGA demonstrated clinicopathological characteristics similar to ETGA. MUC5AC expression was associated with LVI (P = 0.034) and MUC6 (P = 0.017) in EPGA. Moreover, high expression of MUC5AC showed good diagnostic efficiency in distinguishing EPGA (AUC = 0.724, 95% CI = 0.66–0.79). When EGC infiltrated the submucosa (OR = 25.227, 95% CI = 4.017–158.432; P < 0.001) or exhibited MSI-H phenotypes (OR = 10.708, 95% CI = 1.478–77.565; P = 0.019), LVI was more likely to occur. The retrospective study elucidates the clinicopathological features and mucin expression profiles of EPGA. The complex architecture and pronounced nuclear atypia observed in high-grade EPGA are indicative of higher malignancy. Moreover, the high expression of MUC5AC suggests a strong likelihood of EPGA, which may aid in its differentiation. In addition, MSI correlates with the presence of LVI in EGC.
- 4 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessClinicopathological features and mucin expression of early papillary gastric adenocarcinoma
Early papillary gastric adenocarcinoma (EPGA), a well-differentiated gastric adenocarcinoma, is characterized by higher malignancy and worse prognosis compared to other differentiated gastric adenocarcinomas. Therefore, there is a critical need to elucidate its clinicopathological features and mucin expression for accurate diagnosis. The data of 116 cases of EPGA and 116 cases of early well-moderately differentiated tubular gastric adenocarcinoma (ETGA) diagnosed via pathological examination following radical gastrectomy from January 2016 to December 2023 at the Second Hospital of Shandong University were collected. Multivariable logistic regression was used to conduct a comparative analysis of the two groups of variables. The features of histological grading and immunophenotype, particularly mucin expression, were specifically analyzed. The receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic efficacy of potential biomarkers in distinguishing EPGA from ETGA. The features of histological grading and MUC5AC expression in EPGA were specifically analyzed. Additionally, the risk factors of LVI in early gastric cancer (EGC) were assessed. EPGA exhibited significantly larger size (P < 0.001), higher frequencies of elevated appearance (P = 0.001), ulcer formation (P = 0.010) and lymphovascular invasion (LVI, P = 0.050) compared to ETGA. The expression of mismatch repair-deficient (P = 0.005) and MUC5AC (P < 0.001) were significantly elevated in EPGA compared to ETGA. Compared to ETGA, high-grade EPGA exhibited a greater incidence of ulcer formation (P < 0.001), submucosal invasion (P = 0.007), LVI (P = 0.010) and microsatellite instability-high (MSI-H, P < 0.001), whereas low-grade EPGA demonstrated clinicopathological characteristics similar to ETGA. MUC5AC expression was associated with LVI (P = 0.034) and MUC6 (P = 0.017) in EPGA. Moreover, high expression of MUC5AC showed good diagnostic efficiency in distinguishing EPGA (AUC = 0.724, 95% CI = 0.66–0.79). When EGC infiltrated the submucosa (OR = 25.227, 95% CI = 4.017–158.432; P < 0.001) or exhibited MSI-H phenotypes (OR = 10.708, 95% CI = 1.478–77.565; P = 0.019), LVI was more likely to occur. The retrospective study elucidates the clinicopathological features and mucin expression profiles of EPGA. The complex architecture and pronounced nuclear atypia observed in high-grade EPGA are indicative of higher malignancy. Moreover, the high expression of MUC5AC suggests a strong likelihood of EPGA, which may aid in its differentiation. In addition, MSI correlates with the presence of LVI in EGC.
- Open Access
- 25 April 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1396281
Case report: A rare case of very well-differentiated gastric adenocarcinoma of gastric type with a lymphovascular invasion
Background: Very well-differentiated gastric adenocarcinoma (VWDA) is a rare variant of gastric cancer, for which the diagnostic criteria and clinical behavior are not fully established. We reported a case of an intramucosal VWDA of gastric type with a lymphovascular invasion (LVI).Case presentation: A 67-year-old female was diagnosed as intramucosal gastric adenocarcinoma after a biopsy at the local hospital 3 weeks ago and then visited our hospital for further treatment. The endoscopic examination in our hospital showed a rough, slightly faded, 30-mm, flat, and elevated lesion on the lesser curvature of the middle gastric body. Histopathologically, the lesion consisted of superficial foveolar-type papillary adenocarcinoma and deep pyloric gland-type tubular adenocarcinoma. The immunostaining results showed that the foveolar-type papillary adenocarcinoma was positive for MUC5AC and had a high index of Ki-67, but the pyloric gland-type tubular adenocarcinoma was positive for MUC6 and had a low index of Ki-67. Both components were negative for MSH2 and MSH6, which suggested the high microsatellite instability phenotype. Moreover, a LVI was detected in the lesion. The pathological diagnosis was VWDA of gastric type.Conclusion: The case has unique histological and immunophenotypic characteristics, which not only indicates the importance of architectural features in the diagnosis of VWDA but also further proves that the aggressive behavior of VWDA is correlated with tumor histological type and immunophenotype.
- 25 April 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1396281
Open AccessCase report: A rare case of very well-differentiated gastric adenocarcinoma of gastric type with a lymphovascular invasion
Background: Very well-differentiated gastric adenocarcinoma (VWDA) is a rare variant of gastric cancer, for which the diagnostic criteria and clinical behavior are not fully established. We reported a case of an intramucosal VWDA of gastric type with a lymphovascular invasion (LVI).Case presentation: A 67-year-old female was diagnosed as intramucosal gastric adenocarcinoma after a biopsy at the local hospital 3 weeks ago and then visited our hospital for further treatment. The endoscopic examination in our hospital showed a rough, slightly faded, 30-mm, flat, and elevated lesion on the lesser curvature of the middle gastric body. Histopathologically, the lesion consisted of superficial foveolar-type papillary adenocarcinoma and deep pyloric gland-type tubular adenocarcinoma. The immunostaining results showed that the foveolar-type papillary adenocarcinoma was positive for MUC5AC and had a high index of Ki-67, but the pyloric gland-type tubular adenocarcinoma was positive for MUC6 and had a low index of Ki-67. Both components were negative for MSH2 and MSH6, which suggested the high microsatellite instability phenotype. Moreover, a LVI was detected in the lesion. The pathological diagnosis was VWDA of gastric type.Conclusion: The case has unique histological and immunophenotypic characteristics, which not only indicates the importance of architectural features in the diagnosis of VWDA but also further proves that the aggressive behavior of VWDA is correlated with tumor histological type and immunophenotype.
- 3 January 2012
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 16 (4) , 235-244
The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions
- 3 January 2012
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 16 (4) , 235-244
The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions
- 1 February 2011
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 15 (1) , 46-51
Nuclear and cytoplasmic Id-1 expression patterns play different roles in angiogenesis and lymphangiogenesis in gastric carcinoma
- 1 February 2011
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 15 (1) , 46-51
Nuclear and cytoplasmic Id-1 expression patterns play different roles in angiogenesis and lymphangiogenesis in gastric carcinoma
- 19 January 2011
- Published by Wiley in Diagnostic Cytopathology
- Vol. 39 (2) , 105-109
Elevated expression of SOX9 is related with the progression of gastric carcinoma
To investigate the SOX9 expression and its effects on promoting invasion and metastasis in the primary gastric adenocarcinomas. One hundred and eighty six patients with primary gastric adenocarcinomas who underwent surgery between 2002 and 2006 were classified as low, intermediate, and high SOX9 expression groups by immunohistochemistry (IHC). Our IHC performance showed that SOX9 was lowly expressed in lower crypt of the normal epithelium adjacent to the tumor, and SOX9 expression was also observed in the intestinal metaplastic epithelium, but no SOX9 expression was detected in the surface epithelium. The stronger SOX9 expression was observed in the T3-T4 group than in the T1-T2 group, and there was a significant difference between the two groups (P < 0.0005). The SOX9 expression was correlated with the lymph node metastasis, and it showed significant between N0, N1, N2, and N3 groups (P < 0.0005). Similar to the lymph node metastasis classification, the SOX9 expression was also related to the tumor staging. From the stage Ia–Ib to stage II–IIIa and stage IIIb–IV, the SOX9 expression was elevated and the difference was significant (P < 0.0005). On the contrary, the SOX9 expression was not related to the histological classification (P > 0.05). Also the SOX9 expression showed no significance in patient age (P > 0.05). The SOX9 is overexpressed in the advanced stage of gastric carcinoma. SOX9 is related to the tumor progression though promoting invasion and metastasis, probably via enhancing the adhesion between the tumor cells and matrix or vessels which facilitates the tumor cells metastasis. Diagn. Cytopathol. 2011;39:105–109.
- 19 January 2011
- Published by Wiley in Diagnostic Cytopathology
- Vol. 39 (2) , 105-109
Elevated expression of SOX9 is related with the progression of gastric carcinoma
To investigate the SOX9 expression and its effects on promoting invasion and metastasis in the primary gastric adenocarcinomas. One hundred and eighty six patients with primary gastric adenocarcinomas who underwent surgery between 2002 and 2006 were classified as low, intermediate, and high SOX9 expression groups by immunohistochemistry (IHC). Our IHC performance showed that SOX9 was lowly expressed in lower crypt of the normal epithelium adjacent to the tumor, and SOX9 expression was also observed in the intestinal metaplastic epithelium, but no SOX9 expression was detected in the surface epithelium. The stronger SOX9 expression was observed in the T3-T4 group than in the T1-T2 group, and there was a significant difference between the two groups (P < 0.0005). The SOX9 expression was correlated with the lymph node metastasis, and it showed significant between N0, N1, N2, and N3 groups (P < 0.0005). Similar to the lymph node metastasis classification, the SOX9 expression was also related to the tumor staging. From the stage Ia–Ib to stage II–IIIa and stage IIIb–IV, the SOX9 expression was elevated and the difference was significant (P < 0.0005). On the contrary, the SOX9 expression was not related to the histological classification (P > 0.05). Also the SOX9 expression showed no significance in patient age (P > 0.05). The SOX9 is overexpressed in the advanced stage of gastric carcinoma. SOX9 is related to the tumor progression though promoting invasion and metastasis, probably via enhancing the adhesion between the tumor cells and matrix or vessels which facilitates the tumor cells metastasis. Diagn. Cytopathol. 2011;39:105–109.
- 1 October 2009
- Published by Elsevier in Oral Oncology
- Vol. 45 (10) , 883-886
CEACAM1 distribution and it’s effects on angiogenesis and lymphangiogenesis in oral carcinoma
- 1 October 2009
- Published by Elsevier in Oral Oncology
- Vol. 45 (10) , 883-886
CEACAM1 distribution and it’s effects on angiogenesis and lymphangiogenesis in oral carcinoma
- 24 February 2009
- Published by Elsevier in Pathology - Research and Practice
- Vol. 205 (7) , 483-489
The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas
- 24 February 2009
- Published by Elsevier in Pathology - Research and Practice
- Vol. 205 (7) , 483-489
The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas